• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidolactams Imidolactams
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidolactams

3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile (CAS No. 122799-98-8): An Overview of a Promising Compound in Medicinal Chemistry

3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile (CAS No. 122799-98-8) is a versatile and intriguing compound that has garnered significant attention in the field of medicinal chemistry. This compound, characterized by its unique structural features, has shown potential in various therapeutic applications, particularly in the development of novel drugs for the treatment of neurological disorders and cancer. This article aims to provide a comprehensive overview of 3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile, including its chemical properties, synthesis methods, biological activities, and recent research advancements.

Chemical Properties and Structure

3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile is a small molecule with a molecular formula of C₁₀H₁₃N₃. The compound features a pyrazole ring system with a cyclopentyl substituent at the 1-position and an amino group at the 3-position. The presence of the cyano group at the 4-position adds to its chemical versatility and reactivity. The cyclopentyl substituent contributes to the compound's lipophilicity, which is crucial for its ability to cross biological membranes and reach target sites within cells.

The unique combination of these functional groups endows 3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile with a range of physicochemical properties that make it an attractive candidate for drug development. Its molecular weight is 175.23 g/mol, and it has a melting point of approximately 95°C. The compound is soluble in common organic solvents such as dimethyl sulfoxide (DMSO) and ethanol, making it suitable for various experimental protocols.

Synthesis Methods

The synthesis of 3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile has been extensively studied, and several methods have been reported in the literature. One common approach involves the reaction of cyclopentylhydrazine with cyanoacetic acid or its derivatives under appropriate conditions. This method typically yields high purity products with good yields. Another synthetic route involves the condensation of cyclopentylhydrazine with α-cyanoketones, followed by cyclization to form the pyrazole ring.

The choice of synthetic method often depends on factors such as availability of starting materials, reaction conditions, and desired scale of production. Recent advancements in green chemistry have also led to the development of more environmentally friendly and sustainable synthesis methods for this compound, which is an important consideration in modern drug development.

Biological Activities and Therapeutic Potential

3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile has demonstrated a wide range of biological activities that make it a promising candidate for various therapeutic applications. One of its most notable properties is its ability to act as a potent inhibitor of specific enzymes involved in disease pathways. For example, studies have shown that this compound can effectively inhibit the activity of certain kinases, which are key enzymes in signal transduction pathways associated with cancer progression.

In addition to its anti-cancer properties, 3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile has also been investigated for its potential in treating neurological disorders. Research has indicated that this compound can modulate neurotransmitter systems and exert neuroprotective effects, making it a potential candidate for the treatment of conditions such as Alzheimer's disease and Parkinson's disease.

Clinical Trials and Research Advancements

The therapeutic potential of 3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile has led to several preclinical studies and early-stage clinical trials. Preclinical studies have consistently shown that this compound exhibits favorable pharmacokinetic properties, including good oral bioavailability and low toxicity profiles. These findings have paved the way for further clinical evaluation.

In recent clinical trials, 3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile has been tested for its efficacy in treating various cancers, including breast cancer and lung cancer. Preliminary results have been promising, with the compound demonstrating significant anti-tumor activity without causing severe side effects. Ongoing research is focused on optimizing dosing regimens and exploring combination therapies to enhance its therapeutic benefits.

FUTURE DIRECTIONS AND CONCLUSIONS

The future prospects for 3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile are bright, given its diverse biological activities and promising preclinical and clinical data. Further research is needed to fully elucidate its mechanisms of action and identify new therapeutic applications. Additionally, efforts to improve its pharmacological properties through chemical modifications or formulation strategies will be crucial for advancing this compound into later stages of clinical development.

In conclusion, 3-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile (CAS No. 122799-98-8) represents a promising lead compound in medicinal chemistry with significant potential for treating various diseases. Its unique structural features and favorable biological activities make it an attractive target for further investigation and development by researchers and pharmaceutical companies alike.

• 827629-53-8(1H-Pyrazole-4-carbonitrile, 5-amino-1-octyl-)
• 827629-52-7(1H-Pyrazole-4-carbonitrile, 3-amino-1-octyl-)
• 827629-51-6(1H-Pyrazole-4-carbonitrile, 3-amino-1-(cyclohexylmethyl)-)
• 159979-70-1(3-amino-1-butyl-1H-Pyrazole-4-carbonitrile)
• 261629-02-1(3-amino-1-propyl-1H-Pyrazole-4-carbonitrile)
• 89159-00-2(5-amino-1-pentyl-1H-Pyrazole-4-carbonitrile)
• 159979-71-2(3-amino-1-(3-methylbutyl)-1H-Pyrazole-4-carbonitrile)
• 936940-47-5(1-Cyclopentyl-4-methyl-1H-pyrazol-5-amine)
• 89897-29-0(3-Amino-1-isopropyl-1H-pyrazole-4-carbonitrile)
• 30929-67-0(5-Amino-1-cyclopentyl-1H-pyrazole-4-carbonitrile)